Abstract
Dicer is a protein that plays a pivotal role in the final steps of the microRNA (miRNA) processing pathway, to produce mature miRNAs from their precursor molecules. The purpose of the current study was to assess the biological and prognostic value of Dicer protein expression in breast cancer (BC). Dicer protein expression was assessed immunohistochemically in two sets of BC: (1) full-face sections of selected BC series with distinct stages of tumour progression (normal, in situ (DCIS), primary invasive BC and nodal metastases) to evaluate its differential expression. (2) Tissue microarray comprising a large and well-characterised series of unselected clinically annotated invasive BC (n = 1,174) to investigate its correlation with clinicopathological features and patient outcome. A gradual loss of Dicer protein expression was observed in malignant compared to normal breast tissues, with the loss being the least in DCIS and most prominent in metastatic malignant cells. In invasive BC, loss of Dicer expression was associated with features of aggressive behaviour including higher histological grade, loss of hormone receptor and BRCA1 protein expression and with shorter disease-free survival (DFS). Dicer expression was an independent predictor of recurrence in the aggressive HER2-positive subgroup. Moreover, loss of Dicer was predictive of better response to chemotherapy and to endocrine therapy. This study provides evidence that Dicer protein plays a role in human BC progression and behaviour, and assessment of its expression could provide prognostic information in BC including the HER2-positive class.
Similar content being viewed by others
References
Reinhart BJ et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901–906
Hutvagner G et al (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293(5531):834–838
Khoshnaw SM et al (2009) MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 62(5):422–428
Bernstein E et al (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409(6818):363–366
Lau PW et al (2012) The molecular architecture of human Dicer. Nat Struct Mol Biol 19(4):436–440
Lee YS et al (2004) Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117(1):69–81
Houghton J et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306(5701):1568–1571
Bernstein E et al (2003) Dicer is essential for mouse development. Nat Genet 35(3):215–217
Fukagawa T et al (2004) Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol 6(8):784–791
Murchison EP et al (2005) Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 102(34):12135–12140
Blenkiron C et al (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8(10):R214
Zheng ZH et al (2007) Decreased expression of Dicer-1 in gastric cancer. Chin Med J (Engl) 120(23):2099–2104
Karube Y et al (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96(2):111–115
Kumar MS et al (2009) Dicer-1 functions as a haploinsufficient tumor suppressor. Genes Dev 23(23):2700–2704
Martello G et al (2010) A microRNA targeting dicer for metastasis control. Cell 141(7):1195–1207
Chiosea S et al (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67(5):2345–2350
Wong MP et al (2002) Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. Cancer Res 62(15):4464–4468
Zhang L et al (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103(24):9136–9141
Rakha EA et al (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208(4):495–506
Rakha EA et al (2007) Prognostic markers in triple-negative breast cancer. Cancer 109(1):25–32
Rakha EA et al (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18(10):1295–1304
Abd El-Rehim DM et al (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116(3):340–350
Rakha EA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302–2310
Galea MH et al (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22(3):207–219
El-Rehim DM et al (2004) Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer 91(8):1532–1542
Rakha EA et al (2010) Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol 34(10):1472–1479
Kononen J et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844–847
Flavin RJ et al (2008) Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod Pathol 21(6):676–684
McCarty KS Jr et al (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109(8):716–721
McShane L et al (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK)
Grelier G et al (2009) Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 101(4):673–683
Vaksman O et al (2012) Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Hum Pathol. doi:10.1016/j.humpath.2012.02.016
Passon N et al (2012) Expression of Dicer and Drosha in triple-negative breast cancer. J Clin Pathol 65:320–326
Lee Y et al (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21(17):4663–4670
Somasundaram K (2003) Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair–perhaps through transcription. J Cell Biochem 88(6):1084–1091
Paull TT et al (2001) Direct DNA binding by BRCA1. Proc Natl Acad Sci USA 98(11):6086–6091
Moskwa P et al (2011) miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 41(2):210–220
Garcia AI et al (2011) Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 3(5):279–290
Heyn H et al (2011) MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer 129(12):2797–2806
Faggad A et al (2010) Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol 220(3):382–391
Chiosea S et al (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169(5):1812–1820
Chiosea SI et al (2008) Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch 452(6):629–635
Cheng C et al (2009) mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol 10(9):R90
Dedes KJ et al (2011) Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer 47(1):138–150
Yan M et al (2011) Dysregulated expression of Dicer and Drosha in breast cancer. Pathol Oncol Res 18:343–348
Shu GS, Yang ZL, Liu DC (2012) Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathol Res Pract 208(7):392–397
Lin RJ et al (2010) microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 70(20):7841–7850
Noh H et al (2011) Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression. Genes Cancer 2(2):140–150
Faber C et al (2011) Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 47(9):1414–1419
Conflicts of interest
The authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khoshnaw, S.M., Rakha, E.A., Abdel-Fatah, T.M. et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Res Treat 135, 403–413 (2012). https://doi.org/10.1007/s10549-012-2169-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-012-2169-3